Realhealth7

Terms & Conditions

 

CONFIDENTIAL

PLEASE READ THE DISCLAIMER AT THE BOTTOM OF THIS FORM   

DISCLAIMER –  By agreeing to be a member all terms and condition are valid and  legally binding      

Most products purchased by  members are classed as experimental under certain circumstances, therefore no liability is taken by realhealth7, agents, and associates.                                                                                  

DISCLAIMER – To comply with the present Therapeutic Goods Administration legislation all volunteers participating in the Asyra Bioresonance  research and development project must acknowledge the following before participation,

Until the Asyra Bioresonance  or any of  Realhealth7 research material is registered in Australia through the Australian Registrar of Therapeutic Goods, all research data collected must NOT be considered medical advice or is in ANY WAY  intended to diagnose, treat or cure any disease.  Always consult your health care professional when dealing with any health matters.

Volunteer registration information and general disclaimer:

I acknowledge that the purpose of the Asyra Bioresonance Products Research and Development Project is to collect research data using non invasive and inexpensive tools.  However since the Asyra Bioresonance  is currently pending registration on the ARTG all data or information must not be considered medical advice and or intended to treat or cure any disease.

Disclosure within clinical trials

The first international codification of principles to guide clinical researchers involved in medical research is known as The Declaration of Helsinki. This document entitled “Ethical Principles for Medical Research Involving Human Subjects” was adopted by the 18th World Medical Association general assembly meeting in Helsinki, in June 1964. Its 13th principle reads, “In any research on Human beings, and men and women, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study, and the discomfort it might entail. The subject should be informed of the right to abstain from participation in the study or to withdraw consent to participate at any time without reprisal. After ensuring that the subject has understood the information, the physician should then obtain the subject’s freely-given informed consent, preferably in writing. In the United States, codification of human research began when the National Research Act, creating “the National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research”, was signed into law on July 12, 1974.